Nutex Health (NASDAQ:NUTX) Reaches New 1-Year High – Time to Buy?

Nutex Health Inc. (NASDAQ:NUTX)’s share price hit a new 52-week high on Monday . The company traded as high as $204.06 and last traded at $206.8640, with a volume of 11840 shares. The stock had previously closed at $195.20.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the company. Wall Street Zen downgraded Nutex Health from a “buy” rating to a “hold” rating in a research report on Saturday, September 5th. Lake Street Capital reissued a “buy” rating and issued a $310.00 price target (up from $235.00) on shares of Nutex Health in a research note on Tuesday, August 11th. B. Riley Financial lifted their price target on Nutex Health from $290.00 to $325.00 and gave the company a “buy” rating in a report on Friday, September 4th. Zacks Research raised shares of Nutex Health from a “hold” rating to a “strong-buy” rating in a research note on Monday, August 24th. Finally, B Riley reiterated a “buy” rating on shares of Nutex Health in a report on Friday, September 4th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $317.50.

Nutex Health Trading Up 4.0%

The company has a debt-to-equity ratio of 0.59, a quick ratio of 4.96 and a current ratio of 5.00. The firm has a market capitalization of $1.43 billion, a price-to-earnings ratio of 8.19 and a beta of 0.28. The business has a fifty day moving average price of $176.69 and a 200 day moving average price of $140.29.

Nutex Health (NASDAQ:NUTX) last issued its earnings results on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, beating analysts’ consensus estimates of $4.95 by $4.43. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%.The firm had revenue of $210.75 million for the quarter, compared to analysts’ expectations of $215.03 million. As a group, equities analysts forecast that Nutex Health Inc. will post 27.58 earnings per share for the current year.

Hedge Funds Weigh In On Nutex Health

Several hedge funds and other institutional investors have recently modified their holdings of NUTX. Kilter Group LLC acquired a new stake in Nutex Health during the 2nd quarter worth approximately $27,000. Islay Capital Management LLC acquired a new position in Nutex Health during the fourth quarter valued at approximately $34,000. Allworth Financial LP purchased a new stake in Nutex Health during the second quarter worth approximately $35,000. BNP Paribas Financial Markets grew its stake in Nutex Health by 966.7% during the second quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock worth $40,000 after buying an additional 290 shares during the period. Finally, Royal Bank of Canada increased its position in shares of Nutex Health by 752.4% in the fourth quarter. Royal Bank of Canada now owns 358 shares of the company’s stock worth $59,000 after acquiring an additional 316 shares in the last quarter. 5.32% of the stock is owned by institutional investors and hedge funds.

About Nutex Health

Nutex Health Inc (NASDAQ:NUTX) is a physician-led healthcare services company that operates an integrated network of hospitals, outpatient facilities and physician practices. The company focuses on delivering emergency, inpatient and outpatient care through community-based healthcare facilities, including micro-hospitals designed to provide essential hospital services in convenient local settings.

Its services may include emergency medicine, primary care, specialty care, diagnostic testing, imaging, laboratory services and other ancillary healthcare offerings.